Patents Assigned to APPLIED BIORESEARCH, INC.
  • Chelation suppository for improved drug delivery
    Patent number: 9205070
    Abstract: Described herein is a method of delivering drugs to the blood stream directly by absorption through cell membranes in the wall of the rectum from a rectal suppository comprising a glyceride based excipient More specifically, CaNa2 EDTA is delivered rectally from a suppository containing water soluble, glyceride based excipient/carrier.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: December 8, 2015
    Assignee: APPLIED BIORESEARCH, INC.
    Inventors: Robert A. Settineri, Ernest H. Pfadenhauer
  • Direct Lipid to Membrane Drug Delivery
    Publication number: 20140275259
    Abstract: Described herein is a method of delivering hydrophilic drugs directly from a hydrophobic carrier and/or excipient to absorbing cell membranes. More specifically, CaNa2 EDTA is delivered rectally from a suppository containing methylbutylketone in a carrier as an excipient.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: APPLIED BIORESEARCH, INC.
    Inventors: James F. Palmer, Robert A. Settineri
  • Chelation Suppository for Improved Drug Delivery
    Publication number: 20140275258
    Abstract: Described herein is a method of delivering drugs to the blood stream directly by absorption through cell membranes in the wall of the rectum from a rectal suppository comprising a glyceride based excipient More specifically, CaNa2 EDTA is delivered rectally from a suppository containing water soluble, glyceride based excipient/carrier.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: APPLIED BIORESEARCH, INC.
    Inventors: Robert A. Settineri, Ernest H. Pfadenhauer